REVIVO BioSystems is an innovative and service-oriented startup founded by a team of engineers and biologists, with many years of experience in biomedical engineering, cell cultures, microfluidics and tissue engineering.


Aiming to become the Asian and global leading provider of enabling technologies and services for ex vivo and in vitro testing of chemicals, ingredients, cosmetic formulations and therapeutics, our goal is to deliver products and services with unmatched quality, consistency, reproducibility, and ease-of-use.


Our novel testing platforms enable realistic studies and cost enhancement versus other models and traditional methods.

Dr. Bert Grobben

CBO / Co-Founder

Dr. Massimo Alberti

CEO / Founder

Prof. Sriram Gopu 

Scientific Advisor / Co-Founder

  • LinkedIn
  • LinkedIn
  • LinkedIn

Advisory Board Members

Ad Ketelaars

Dr. Alain Khaiat

Dr. Chris Thoen

  • LinkedIn
  • LinkedIn
  • LinkedIn

Dr. Akira Date

  • LinkedIn

REVIVO BioSystems is a Singapore Headquartered spin-off from A*STAR. that has it's genesis in a 2014 Skin-on-Chip research program. 


Our founding team invented and developed REVIVO's platform of explants-on-chip and skin-on-chip technology at the Singapore Institute of Manufacturing Technology and the Institute of Medical Biology in A*STAR.

Our Partners

ASTAR_SIMTech_Horizontal Logo_RGB copy.p
BI logo.png

Dr. Zhiping Wang

Scientific Advisor / Co-Founder

  • LinkedIn

Subscribe to receive updates on our products, services and activities

For queries and more information

please contact

And follow us on

  • LinkedIn - White Circle
  • Facebook
  • Twitter

© 2020 by REVIVO Biosystems Pte. Ltd